1.27

2.42% 0.03

After Hours: 1.26 -0.01 -0.79%

Bionano Genomics Inc (BNGO)

Overview News Price History Option Chain Financials Why BNGO Down? Discussions Forecast Stock Split

Bionano Genomics Inc stock is traded at $1.27, with a volume of 114.26K. It is up +2.42% in the last 24 hours and up +10.43% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Previous Close:

$1.24

Open:

$1.23

24h Volume:

114.26K

Relative Volume:

0.41

Market Cap:

$14.09M

Revenue:

$28.51M

Net Income/Loss:

$-26.40M

P/E Ratio:

-0.2319

EPS:

-5.4756

Net Cash Flow:

$-16.35M

1W Performance:

+9.48%

1M Performance:

+10.43%

6M Performance:

-21.12%

1Y Performance:

-65.68%

1-Day Range:

$1.22

$1.29

1-Week Range:

$1.15

$1.29

52-Week Range:

$1.06

$5.50

Bionano Genomics Inc Stock (BNGO) Company Profile

Name

Bionano Genomics Inc

Sector

Healthcare (1111)

Industry

Medical Instruments & Supplies (56)

Phone

(858) 888-7600

Address

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

Employee

Twitter

@bionanogenomics

Next Earnings Date

2026-05-13

Latest SEC Filings

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNGO Bionano Genomics Inc	1.27	13.75M	28.51M	-26.40M	-16.35M	-5.4756
ISRG Intuitive Surgical Inc	451.73	159.86B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	144.76	41.01B	21.92B	1.76B	2.63B	6.1223
MDLN Medline Inc	42.01	38.32B	28.43B	1.16B	1.26B	1.4457
ALC Alcon Inc	65.41	36.29B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	209.64	30.15B	5.54B	1.52B	1.74B	10.37

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-12-22	Resumed	BTIG Research	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Jun-16-21	Initiated	BTIG Research	Buy
Sep-24-20	Initiated	Ladenburg Thalmann	Buy
Apr-08-20	Initiated	Oppenheimer	Outperform

View All

Bionano Genomics Inc Stock (BNGO) Latest News

04:46 AM

Bionano appoints board chairman as interim CEO By Investing.com - Investing.com Australia

04:46 AM

04:30 AM

Al Luderer becomes interim CEO at Bionano Genomics (NASDAQ: BNGO) - Stock Titan

04:30 AM

Bionano Announces Leadership Transition - The Globe and Mail

04:30 AM

May 05, 2026

Bionano reports 56% jump in rare disease research publications By Investing.com - Investing.com Australia

May 05, 2026

Bionano reports 56% jump in rare disease research publications - Investing.com

May 05, 2026

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - The Manila Times

May 05, 2026

28 rare-disease studies back genome mapping for unresolved cases - Stock Titan

May 05, 2026

May 01, 2026

BNGO Should I Buy - Intellectia AI

May 01, 2026

Apr 29, 2026

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - The Globe and Mail

Apr 29, 2026

Bionano schedules May 13 webcast to discuss first-quarter results - Stock Titan

Apr 29, 2026

Apr 27, 2026

Bionano Genomics stock rises on Q1 revenue beat - MSN

Apr 27, 2026

Apr 26, 2026

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN

Apr 26, 2026

Apr 22, 2026

BNGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 22, 2026

Apr 18, 2026

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN

Apr 18, 2026

Apr 13, 2026

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Apr 13, 2026

BNGO Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

Apr 13, 2026

Take Profit: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Investment Report & Community Driven Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Keys to Succeed in the Booming $300 Million Optical Genome - GlobeNewswire

Apr 13, 2026

Breakout Zone: What is Bionano Genomics Incs P E ratio telling us2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn

Apr 13, 2026

Aug Update: Is Bionano Genomics Inc part of any ETFQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn

Apr 13, 2026

Bionano Genomics stock price target lowered to $6 by H.C. Wainwright - Investing.com South Africa

Apr 13, 2026

Apr 07, 2026

Is Bionano (BNGO) Stock Stronger Than Peers | Price at $1.17, Up 1.74%Strong Buy Rating - Cổng thông tin điện tử tỉnh Lào Cai

Apr 07, 2026

Apr 06, 2026

Weekly Recap: Is Bionano Genomics Inc stock a value trap2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail

Apr 04, 2026

Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN

Apr 04, 2026

Apr 03, 2026